Real-world experience with implantable loop recorder monitoring to detect subclinical atrial fibrillation in patients with cryptogenic stroke: The value of p wave dispersion in predicting arrhythmia occurrence.


Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
15 03 2021
Historique:
received: 20 08 2020
revised: 27 10 2020
accepted: 05 11 2020
pubmed: 14 11 2020
medline: 29 5 2021
entrez: 13 11 2020
Statut: ppublish

Résumé

We hypothesized patients implanted with ILRs for cryptogenic stroke in "real life" clinical practice will show an AF detection rate comparable to prior clinical studies, and that clinical or imaging features may help to identify those at higher risk of AF detection. A retrospective chart review was conducted of all patients who presented with cryptogenic stroke and received an ILR at an academic medical center from 2015 to 2017 with an active inpatient stroke service. The electronic health record and remote monitoring were used to identify occurrence of AF. A total of 178 patients who received ILRs for cryptogenic stroke were included. Overall, after a thorough evaluation for other etiologies of stroke, 35 (19.6%) were found to have AF detected. Mean follow-up was 365 days with a median time to detection of 131 days. Advanced age (p = 0.001), diastolic dysfunction on echo (p = 0.03), as well as ECG findings of premature atrial contractions (PACs) and p wave dispersion (PWD) > 40 ms were found to be predictive of AF detection (p = 0.04, p < 0.001, respectively). On multiple regression analysis, the only independent predictor of AF detection was PWD > 40 ms. After a thorough evaluation to exclude other etiologies for stroke, approximately 20% of patients of our cryptogenic stroke population were found to have AF with ILR surveillance. Advanced age, diastolic dysfunction, as well as ECG findings of PACs and increased PWD may help to predict those at higher risk of AF detection, while PWD was the only independent predictor. This has important clinical implications, as better prediction of AF may help identify those at highest risk and might subsequently aid in guiding therapy.

Identifiants

pubmed: 33186666
pii: S0167-5273(20)34140-1
doi: 10.1016/j.ijcard.2020.11.019
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

86-92

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

Daniel Marks (D)

Division of Cardiology, Cooper Medical School of Rowan University, Camden, NJ, United States of America. Electronic address: Daniel.marks@northwestern.edu.

Rady Ho (R)

Division of Cardiology, Cooper Medical School of Rowan University, Camden, NJ, United States of America. Electronic address: rho2@mgh.Harvard.edu.

Ryna Then (R)

Division of Cardiology, Cooper Medical School of Rowan University, Camden, NJ, United States of America. Electronic address: Then-Ryna@cooperhealth.edu.

Joshua L Weinstock (JL)

Division of Cardiology, Cooper Medical School of Rowan University, Camden, NJ, United States of America. Electronic address: Weinstock-joshua@cooperhealth.edu.

Ephrem Teklemariam (E)

Division of Cardiology, Cooper Medical School of Rowan University, Camden, NJ, United States of America. Electronic address: Teklemariam-Ephrem@cooperhealth.edu.

Bhavika Kakadia (B)

Division of Cardiology, Cooper Medical School of Rowan University, Camden, NJ, United States of America. Electronic address: Kakadia-Bhavika@cooperhealth.edu.

Jared Collins (J)

Division of Cardiology, Cooper Medical School of Rowan University, Camden, NJ, United States of America. Electronic address: jaredcollins.do.ep@gmail.com.

John Andriulli (J)

Division of Cardiology, Cooper Medical School of Rowan University, Camden, NJ, United States of America. Electronic address: Andriulli-john@cooperhealth.edu.

Krystal Hunter (K)

Division of Cardiology, Cooper Medical School of Rowan University, Camden, NJ, United States of America. Electronic address: hunter-krystal@cooperhealth.edu.

Matthew Ortman (M)

Division of Cardiology, Cooper Medical School of Rowan University, Camden, NJ, United States of America. Electronic address: Ortman-Matthew@cooperhealth.edu.

Andrea M Russo (AM)

Division of Cardiology, Cooper Medical School of Rowan University, Camden, NJ, United States of America. Electronic address: Russo-andrea@cooperhealth.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH